FDA Issues Recalls For Alaris Infusion Pumps
This article was originally published in The Gray Sheet
Executive Summary
The agency designated two recalls linked to infusion pumps as class I actions based on concerns with a device alarm system in one case and a fluid retention membrane in the other.